University of Iowa Holden Comprehensive Car
Treating two girls with the same rare cancer is more than a coincidence for UI adult and pediatric specialists.
With the conventional first-line drug for early-stage bladder cancer in severe shortage, new therapies developed at Iowa are poised to lead a new wave of care.
Adding immunotherapy improves outcomes f
Holden Cancer Center joins Caris’ extensive network of leading cancer institutions committed to utilizing clinical
Holden Comprehensive Cancer Center among nation’s top cancer organizations to issue joint call to action for increased lung cancer screening
University of Iowa’s Holden Comprehensive Cancer Center has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.
The treatment uses 3D technology to precisely map tumor removal and develop prosthetics that are unique to each patient’s anatomy. It’s helping patients get back to their active lifestyles sooner.
The climate certainly seems to be changing, and there is new urgency in developing a master plan to respond to this new reality.
Benjamin J. Miller, MD, MS, discusses the creation of the Musculoskeletal Tumor Registry and how it is poised to make progress in the orthopedic oncology field with OncLive.
True collaboration should be embedded in the practice of medicine. It should be baked in, a given, something we don’t need to write columns on.